Cited by 82Acne and Rosacea Treatments and EffectsDermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

50 Years of Topical Retinoids for Acne: Evolution of Treatment

Baldwin, Hilary, Webster, Guy, Stein Gold, Linda, Callender, Valerie, Cook-Bolden, Fran E., Guenin, Eric·2021·American Journal of Clinical Dermatology

Abstract

Since the US Food and Drug Administration (FDA) approved tretinoin in 1971, retinoids alone or combined with other agents have become the mainstay of acne treatment. Retinoids act through binding to retinoic acid receptors, altering expression levels of hundreds of cellular proteins affecting multiple pathways involved in acne pathogenesis. Retinoids have evolved from first-generation agents, such as tretinoin, through chemical modifications resulting in a second generation (etretinate and acitretin for psoriasis), a third generation (adapalene and tazarotene) and, most recently, a fourth (trifarotene). For all topical retinoids, local irritation has been associated with poor tolerability and suboptimal adherence. Efforts to improve tolerability have utilized novel delivery systems and/or novel agents. This qualitative literature review summarizes the evolution of the four topical single-agent retinoids available for the treatment of acne in the US today and their various formulations, presenting the rationale behind their development and data from key studies.

Integrity signals

Registry

Crossref · 10.1007/s40257-021-00594-8

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Baldwin, H., Webster, G., Stein Gold, L., Callender, V., Cook-Bolden, F. E., & Guenin, E.
Affiliations
  • Robert Wood Johnson University Hospital (US)
  • Thomas Jefferson University (US)
  • Howard University (US)
  • Mount Sinai Hospital (US)
  • Bausch Health (United States) (US)
Corresponding author
Baldwin, Hilary
Venue
American Journal of Clinical Dermatology
Published
2021-04-19
Volume
22
Issue
3
Pages
315-327
ISSN
  • 1175-0561 (ISSN-L)
  • 1179-1888
OpenAlex
W3156840856
Cited by
82
References
70
Citations by year
2026: 11 · 2025: 18 · 2024: 22 · 2023: 19 · 2022: 7 · 2021: 5
FWCI
2.34
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Clinical Dermatology (publishedVersion)
  • PubMed (publishedVersion)
  • Digital Howard (Howard University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Dermatology › Acne and Rosacea Treatments and Effects
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Keywords
topical retinoids, acne, all-trans retinoic acid, adapalene, tazarotene, trifarotene, etretinate, acitretin, retinoic acid receptor, drug tolerability, medication adherence
MeSH terms
Acne Vulgaris, Administration, Cutaneous, Cell Movement, Dermatologic Agents, Gene Expression Regulation, Humans, Leukocytes, Retinoids, Signal Transduction, Treatment Outcome, Receptors, Retinoic Acid, Toll-Like Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review